Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Olive
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Baxter Secures FDA Approval for Clinolipid in Neonates and Pediatrics
Details : Clinolipid is a mixed oil lipid emulsion providing essential fatty acids and calories in parenteral nutrition when oral or enteral nutrition isn’t viable.
Product Name : Clinolipid
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 13, 2024
Lead Product(s) : Olive
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Olive
Therapeutic Area : Endocrinology
Study Phase : Phase II
Sponsor : Andalusian Health Service | Universidad Pablo de Olavide
Deal Size : Inapplicable
Deal Type : Inapplicable
Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY)
Details : Olive Oil is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Diabetes Mellitus.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
September 11, 2023
Lead Product(s) : Olive
Therapeutic Area : Endocrinology
Highest Development Status : Phase II
Sponsor : Andalusian Health Service | Universidad Pablo de Olavide
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Olive
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Oral Mucositis and Quality of Life With a Mucosa Topical Composition in Head & Neck Cancer Patients.
Details : Olive Oil is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Stomatitis.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
December 02, 2022
Lead Product(s) : Olive
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Olive
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : Lumenis | Mucosa Innovations
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Olive Oil is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Female Urogenital Diseases.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
October 18, 2022
Lead Product(s) : Olive
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : Lumenis | Mucosa Innovations
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Olive
Therapeutic Area : Undisclosed
Study Phase : Phase II/ Phase III
Sponsor : Universidad de Granada
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Olive is a drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 19, 2022
Lead Product(s) : Olive
Therapeutic Area : Undisclosed
Highest Development Status : Phase II/ Phase III
Sponsor : Universidad de Granada
Deal Size : Inapplicable
Deal Type : Inapplicable